Oaktree Acquisition Corp. III Life Sciences (OACC)

NASDAQ: OACC · Real-Time Price · USD
Oaktree Acquisition Corp. III Life Sciences currently trades with the ticker symbol OACCU
10.13
+0.01 (0.10%)
Dec 6, 2024, 4:00 PM EST - Market closed
Market Cap 234.16M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 23.12M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,015
Open 10.12
Previous Close 10.12
Day's Range 10.12 - 10.13
52-Week Range 9.99 - 10.22
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About OACC

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Oct 24, 2024
Country United States
Stock Exchange NASDAQ
Ticker Symbol OACC
Full Company Profile

News

Oaktree Acquisition Corp. III Life Sciences Announces Pricing of $175 Million Initial Public Offering

Oaktree Acquisition Corp. III Life Sciences, a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities...

6 weeks ago - Business Wire

SPAC Oaktree Acquisition III Life Sciences files for a $175 million IPO, formed by Oaktree Capital Management

Oaktree Acquisition III Life Sciences, a blank check company formed by Oaktree Capital targeting healthcare businesses, filed on Friday with the SEC to raise up to $175 million in an initial public of...

2 months ago - Renaissance Capital

Oaktree Acquisition Corp. III Life Sciences IPO Registration Document (S-1)

Oaktree Acquisition Corp. III Life Sciences has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC